Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia
暂无分享,去创建一个
G. Alexander | J. Hardy | E. Reiman | R. Caselli | D. Bandy | Kewei Chen | A. Saunders | D. Osborne | J. Hardy
[1] A. Brun,et al. Distribution of cerebral degeneration in Alzheimer's disease , 1976, Archiv für Psychiatrie und Nervenkrankheiten.
[2] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[3] G. Alexander,et al. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies. , 2002, The American journal of psychiatry.
[4] Chester A. Mathis,et al. A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. , 2002, Bioorganic & medicinal chemistry letters.
[5] G. Alexander,et al. Apolipoprotein E and Intellectual Achievement , 2002, Journal of the American Geriatrics Society.
[6] G. Small,et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease. , 2002, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[7] G. Alexander,et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. , 2001, JAMA.
[8] Richard J. Caselli,et al. Tracking the decline in cerebral glucose metabolism in persons and laboratory animals at genetic risk for Alzheimer's disease , 2001, Clinical Neuroscience Research.
[9] G. Alexander,et al. Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[10] I. Deary,et al. Childhood mental ability and dementia , 2000, Neurology.
[11] J. Mazziotta,et al. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[12] V. Hachinski,et al. Educational attainment and socioeconomic status of patients with autopsy-confirmed Alzheimer disease. , 2000, Archives of neurology.
[13] J. Baron,et al. Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease. , 1999, Brain : a journal of neurology.
[14] K. Ishii,et al. Lack of Association of Apolipoprotein E ε4 Allele Dose with Cerebral Glucose Metabolism in Alzheimer Disease , 1998 .
[15] J. Kessler,et al. Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease , 1998, Neuroscience Letters.
[16] H. Braak,et al. High Frequency of Apolipoprotein E ϵ4 Allele in Young Individuals with Very Mild Alzheimer's Disease-Related Neurofibrillary Changes , 1998, Experimental Neurology.
[17] C. Cotman,et al. Learning upregulates brain-derived neurotrophic factor messenger ribonucleic acid: a mechanism to facilitate encoding and circuit maintenance? , 1998, Behavioral neuroscience.
[18] Daniel Bandy,et al. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease , 1998, Annals of neurology.
[19] D. Feng,et al. Noninvasive Quantification of the Cerebral Metabolic Rate for Glucose Using Positron Emission Tomography, 18F-Fluoro-2-Deoxyglucose, the Patlak Method, and an Image-Derived Input Function , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] G. Alexander,et al. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease , 1998, Neurology.
[21] Karl J. Friston,et al. Human Brain Function , 1997 .
[22] H. Arai,et al. Regional cerebral glucose utilization is modulated by the dosage of apolipoprotein E type 4 allele and α1‐antichymotrypsin type A allele in Alzheimer's disease , 1997, Neuroreport.
[23] H. Braak,et al. Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.
[24] E. Corder,et al. No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes. , 1997, Archives of neurology.
[25] R J Mark,et al. Amyloid β-Peptide Impairs Glucose Transport in Hippocampal and Cortical Neurons: Involvement of Membrane Lipid Peroxidation , 1997, The Journal of Neuroscience.
[26] M. First,et al. Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .
[27] P Pietrini,et al. Association of premorbid intellectual function with cerebral metabolism in Alzheimer's disease: implications for the cognitive reserve hypothesis. , 1997, The American journal of psychiatry.
[28] Jonathan D. Smith,et al. Apolipoprotein E allele–specific antioxidant activity and effects on cytotoxicity by oxidative insults and β–amyloid peptides , 1996, Nature Genetics.
[29] S. Thibodeau,et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.
[30] D R Wekstein,et al. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. , 1996, JAMA.
[31] D E Kuhl,et al. Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[32] P. Magistretti,et al. Cellular bases of brain energy metabolism and their relevance to functional brain imaging: evidence for a prominent role of astrocytes. , 1996, Cerebral cortex.
[33] N. Risch,et al. Statement on use of apolipoprotein E testing for Alzheimer disease. American College of Medical Genetics/American Society of Human Genetics Working Group on ApoE and Alzheimer disease. , 1995, JAMA.
[34] A. Alavi,et al. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[35] N. Foster,et al. Preserved Pontine Glucose Metabolism in Alzheimer Disease: A Reference Region for Functional Brain Image (PET) Analysis , 1995, Journal of computer assisted tomography.
[36] R. Koeppe,et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[37] D. Schaid,et al. Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. , 1995, JAMA.
[38] J C Mazziotta,et al. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. , 1995, JAMA.
[39] Richard S. J. Frackowiak,et al. Deficits in cerebral glucose metabolism demonstrated by positron emission tomography in individuals at risk of familial Alzheimer's disease , 1995, Neuroscience Letters.
[40] H. Braak,et al. Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes , 1995, Neuroscience.
[41] T Vogel,et al. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. , 1994, The American journal of pathology.
[42] R. Mahley,et al. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. , 1994, Science.
[43] R. Mayeux,et al. Influence of education and occupation on the incidence of Alzheimer's disease. , 1994, JAMA.
[44] K Herholz,et al. Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. , 1994, Dementia.
[45] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[46] A. D. Roses,et al. Association of apolipoprotein E allele €4 with late-onset familial and sporadic Alzheimer’s disease , 2006 .
[47] J V Haxby,et al. Pattern of cerebral metabolic interactions in a subject with isolated amnesia at risk for Alzheimer's disease: a longitudinal evaluation. , 1993, Dementia.
[48] M. Pericak-Vance,et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[49] M. Albert,et al. Level of education and change in cognitive function in a community population of older persons. , 1993, Annals of epidemiology.
[50] M J de Leon,et al. Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications. , 1992, Archives of neurology.
[51] C. Coffey,et al. Quantitative cerebral anatomy of the aging human brain , 1992, Neurology.
[52] E. Boerwinkle,et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. , 1991, American journal of human genetics.
[53] C. Degueldre,et al. Decrease of frontal metabolism demonstrated by positron emission tomography in a population of healthy elderly volunteers. , 1991, Acta neurologica Belgica.
[54] M. Torrens. Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .
[55] D. T. Vernier,et al. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. , 1990, Journal of lipid research.
[56] B. L. Beattie,et al. 18Fluorodeoxyglucose Positron Emission Tomography Studies in Presumed Alzheimer Cases, Including 13 Serial Scans , 1990, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[57] Robert L. Spitzer,et al. User's guide for the Structured clinical interview for DSM-III-R : SCID , 1990 .
[58] M. Albert,et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. , 1989, JAMA.
[59] R. Mahley,et al. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.
[60] G. V. Van Hoesen,et al. Perforant pathway changes and the memory impairment of Alzheimer's disease , 1986, Annals of neurology.
[61] Michael E. Phelps,et al. Effects of Human Aging on Patterns of Local Cerebral Glucose Utilization Determined by the [18F] Fluorodeoxyglucose Method , 1982, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[62] W J Schwartz,et al. Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat. , 1979, Science.
[63] S. Folstein,et al. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.
[64] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.